{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:06:45Z","timestamp":1795028805244,"version":"4.10.2"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013885","name":"Kementerian Kesihatan Malaysia","doi-asserted-by":"publisher","award":["NMRR-09-656-4418, NMRR-12-298-11801 , NMRR-16-892-31023"],"award-info":[{"award-number":["NMRR-09-656-4418, NMRR-12-298-11801 , NMRR-16-892-31023"]}],"id":[{"id":"10.13039\/501100013885","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Bruton\u2019s tyrosine kinase (BTK) is a cytoplasmic protein involved in the B cell development. X-linked agammaglobulinemia (XLA) is caused by mutation in the <jats:italic>BTK<\/jats:italic> gene, which results in very low or absent B cells. Affected males have markedly reduced immunoglobulin levels, which render them susceptible to recurrent and severe bacterial infections. Methods: Patients suspected with X-linked agammaglobulinemia were enrolled during the period of 2010-2018. Clinical summary, and immunological profiles of these patients were recorded. Peripheral blood samples were collected for monocyte BTK protein expression detection and <jats:italic>BTK<\/jats:italic> genetic analysis. The medical records between January 2020 and June 2023 were reviewed to investigate COVID-19 in XLA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-two patients (from 16 unrelated families) were molecularly diagnosed as XLA. Genetic testing revealed fifteen distinct mutations, including four splicing mutations, four missense mutations, three nonsense mutations, three short deletions, and one large indel mutation. These mutations scattered throughout the <jats:italic>BTK<\/jats:italic> gene and mostly affected the kinase domain. All mutations including five novel mutations were predicted to be pathogenic or deleterious by <jats:italic>in silico<\/jats:italic> prediction tools. Genetic testing confirmed that eleven mothers and seven sisters were carriers for the disease, while three mutations were <jats:italic>de novo<\/jats:italic>. Flow cytometric analysis showed that thirteen patients had minimal BTK expression (0-15%) while eight patients had reduced BTK expression (16-64%). One patient was not tested for monocyte BTK expression due to insufficient sample. Pneumonia (n=13) was the most common manifestation, while <jats:italic>Pseudomonas aeruginosa<\/jats:italic> was the most frequently isolated pathogen from the patients (n=4). Mild or asymptomatic COVID-19 was reported in four patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This report provides the first overview of demographic, clinical, immunological and genetic data of XLA in Malaysia. The combination of flow cytometric assessment and <jats:italic>BTK<\/jats:italic> genetic analysis provides a definitive diagnosis for XLA patients, especially with atypical clinical presentation. In addition, it may also allow carrier detection and assist in genetic counselling and prenatal diagnosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1252765","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T14:51:20Z","timestamp":1695394280000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia"],"prefix":"10.3389","volume":"14","author":[{"given":"Chai Teng","family":"Chear","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intan Hakimah","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwai Cheng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokman Mohd","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiah","family":"Kassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hamzah Abdul","family":"Latiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep Singh","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazatul Haslina","family":"Ramly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Kee","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Sundaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Ming","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharifah Adlena Syed","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Farid","family":"Baharin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia Suhana","family":"Zamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharifah Nurul Husna Syed","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saharuddin Bin","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adiratna Mat","family":"Ripen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2005.00233.x","article-title":"Genetic analysis of patients with defects in early B-cell development","volume":"203","author":"Conley","year":"2005","journal-title":"Immunol Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9594-7","article-title":"Nationwide survey of patients with primary immunodeficiency diseases in Japan","volume":"31","author":"Ishimura","year":"2011","journal-title":"J Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004544","article-title":"Clinical characteristics and genetic profiles of 174 patients with X-linked agammaglobulinemia: Report from Shanghai, China (2000\u20132015)","volume":"95","author":"Chen","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.03.001","article-title":"Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality","volume":"146","author":"Lougaris","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.612323","article-title":"Clinical and genetic profile of X-linked agammaglobulinemia: A multicenter experience from India","volume":"11","author":"Rawat","year":"2021","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2019.100018","article-title":"X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world","volume":"12","author":"El-Sayed","year":"2019","journal-title":"World Allergy Organ J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90667-F","article-title":"Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia","volume":"72","author":"Tsukada","year":"1993","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.19.9062","article-title":"Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia","volume":"91","author":"Ohta","year":"1994","journal-title":"Proc Natl Acad Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2741\/vihinen","article-title":"Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA)","volume":"5","author":"Vihinen","year":"2000","journal-title":"Front Biosci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104828200","article-title":"Crystal structure of Bruton\u2019s tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia","volume":"276","author":"Mao","year":"2001","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20410","article-title":"BTKbase: The mutation database for X-Linked agammaglobulinemia","volume":"27","author":"Valiaho","year":"2006","journal-title":"Hum Mutat"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.04.043","article-title":"A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia","volume":"116","author":"L\u00f3pez-Granados","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9227-y","article-title":"Clinical and molecular analysis of 49 patients with X-linked agammaglobulinemia from a single center in Argentina","volume":"29","author":"Basile","year":"2008","journal-title":"J Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-313X.2006.00598.x","article-title":"Identification of Bruton tyrosine kinase mutations in 12 Chinese patients with X-linked agammaglobulinaemia by long PCR-direct sequencing","volume":"33","author":"Chan","year":"2006","journal-title":"Int J Immunogenet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1182\/blood.V91.2.595","article-title":"Deficient expression of Bruton\u2019s tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection","volume":"91","author":"Futatani","year":"1998","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02905.x","article-title":"Bruton\u2019s tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females","volume":"114","author":"Futatani","year":"2001","journal-title":"Br J Haematol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12881-020-01063-5","article-title":"Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton\u2019s tyrosine kinase (BTK) gene mutations","volume":"21","author":"Gao","year":"2020","journal-title":"BMC Med Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.7.4038","article-title":"Characterization of mutations, including a novel regulatory defect in the first intron, in Bruton\u2019s tyrosine kinase gene from seven Korean X-linked agammaglobulinemia families","volume":"167","author":"Jo","year":"2001","journal-title":"J Immunol"},{"key":"B20","article-title":"Clinical manifestations and BTK gene defect in 4 unrelated Taiwanese families with Bruton\u2019s disease","volume":"29","author":"Lee","year":"2011","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-009-9341-5","article-title":"Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia","volume":"30","author":"Lee","year":"2009","journal-title":"J Clin Immunol"},{"key":"B22","first-page":"15","article-title":"X-linked agammaglobulinaemia in Hong Kong Chinese","volume":"8","author":"Lobo","year":"2003","journal-title":"HK J Paediatr New Ser"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02001","article-title":"Distinct clinical features and novel mutations in Taiwanese patients with X-linked agammaglobulinemia","volume":"11","author":"Yeh","year":"2020","journal-title":"Front Immunol"},{"key":"B24","first-page":"57","article-title":"X-linked agammaglobulinemia in northern Thailand","volume":"24","author":"Trakultivakorn","year":"2010","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.12932\/AP0304.31.4.2013","article-title":"A novel Bruton\u2019s tyrosine kinase gene (BTK) invariant splice site mutation in a Malaysian family with X-linked agammaglobulinemia","volume":"31","author":"Chear","year":"2013","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2015.02.019","article-title":"A novel BTK gene mutation creates a de-novo splice site in an X-linked agammaglobulinemia patient","volume":"560","author":"Chear","year":"2015","journal-title":"Gene"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1007\/s10875-021-01017-3","article-title":"Atypical presentation of severe fungal necrotizing fasciitis in a patient with X-linked agammaglobulinemia","volume":"41","author":"Chear","year":"2021","journal-title":"J Clin Immunol"},{"key":"B28","first-page":"238","article-title":"Ecthyma gangrenosum as the presenting clinical feature of X-linked agammaglobulinaemia: report of three cases and a review of literature","volume":"34","author":"Ismail","year":"2021","journal-title":"Curr Allergy Clinical Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6836","DOI":"10.1038\/s41598-017-06342-5","article-title":"Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency","volume":"7","author":"Mirsafian","year":"2017","journal-title":"Sci Rep"},{"key":"B30","article-title":"Clinical-epidemiological pattern of primary immunodeficiencies in Malaysia 1987-2006: A 20 year experience in four Malaysian hospitals","volume":"68","author":"Noh","year":"2013","journal-title":"Med J Malaysia"},{"key":"B31","unstructured":"SmithCE\n            Bergl\u00f6fA\n          Seattle (WAUniversity of WashingtonX-Linked Agammaglobulinemia2001"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.2.561.bloodjournal882561","article-title":"Identification of Bruton\u2019s tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan","volume":"88","author":"Hashimoto","year":"1996","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/4.1.51","article-title":"DNA-based mutation analysis of Bruton\u2019s tyrosine kinase gene in patients with X-linked agammaglobulinemia","volume":"4","author":"Vorechovsky","year":"1995","journal-title":"Hum Mol Genet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/humu.20654","article-title":"Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker","volume":"29","author":"Wildeman","year":"2008","journal-title":"Hum Mutat"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1159\/000095469","article-title":"Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia","volume":"141","author":"Aghamohammadi","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0251-z","article-title":"X-linked agammagobulinemia in a large series of north african patients: frequency, clinical features and novel BTK mutations","volume":"8","author":"Aadam","year":"2016","journal-title":"J Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaci.2011.01.052","article-title":"Quantification of \u03ba-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects","volume":"128","author":"Nakagawa","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-371021","article-title":"Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR","volume":"119","author":"Borte","year":"2012","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10875-016-0347-5","article-title":"Newborn screening for severe primary immunodeficiency diseases in Sweden\u2014a 2-year pilot TREC and KREC screening study","volume":"37","author":"Barbaro","year":"2017","journal-title":"J Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-126669","article-title":"Utility of newborn screening for severe combined immunodeficiency and X-linked agammaglobulinemia using TREC and KREC assays","volume":"134","author":"Wakamatsu","year":"2019","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jaci.2011.10.009","article-title":"Toll-like receptor 4\u2013, 7\u2013, and 8\u2013activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines","volume":"129","author":"Marron","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2019.1604742","article-title":"Disturbed transcription of TLRs\u2019 Negative regulators and cytokines secretion among TLR4- and 9-activated PBMCs of agammaglobulinemic patients","volume":"48","author":"Sanaei","year":"2019","journal-title":"Immunol Invest"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI128322","article-title":"Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1\u03b2\u2013mediated colitis","volume":"130","author":"Mao","year":"2020","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2016.07.044","article-title":"X-linked agammaglobulinemia","volume":"117","author":"Singh","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13228","article-title":"Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia","volume":"31","author":"Fekrvand","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Med (Baltimore)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.640168","article-title":"B-cells and antibodies as contributors to effector immune responses in tuberculosis","volume":"12","author":"Rijnink","year":"2021","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13263","article-title":"Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover","volume":"31","author":"Soresina","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01133-0","article-title":"SARS-CoV-2 vaccine induced atypical immune responses in antibody defects: everybody does their best","volume":"41","author":"Salinas","year":"2021","journal-title":"J Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13416","article-title":"The role of Bruton\u2019s tyrosine kinase in the immune system and disease","volume":"164","author":"McDonald","year":"2021","journal-title":"Immunology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000524583","article-title":"Bruton\u2019s tyrosine kinase in neutrophils Is crucial for host defense against Klebsiella pneumoniae","volume":"15","author":"Liu","year":"2023","journal-title":"J Innate Immun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201344030","article-title":"Bruton\u2019s tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells: Innate immunity","volume":"44","author":"Wang","year":"2014","journal-title":"Eur J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.687251","article-title":"Analysis of the effects of the Bruton\u2019s tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fc\u03b3 Receptor (Fc\u03b3R) function","volume":"291","author":"Ren","year":"2016","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15778","article-title":"Bruton\u2019s TK regulates myeloid cell recruitment during acute inflammation","volume":"179","author":"Purvis","year":"2022","journal-title":"Br J Pharmacol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.689892","article-title":"Splicing in the diagnosis of rare disease: advances and challenges","volume":"12","author":"Lord","year":"2021","journal-title":"Front Genet"},{"key":"B56","doi-asserted-by":"publisher","first-page":"282","DOI":"10.12688\/f1000research.5654.1","article-title":"Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis","volume":"3","author":"Caminsky","year":"2014","journal-title":"F1000Research"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1391807","article-title":"X-chromosome inactivation and related diseases","volume":"2022","author":"Sun","year":"2022","journal-title":"Genet Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030535","article-title":"Mechanisms of choice in X-chromosome inactivation","volume":"11","author":"Furlan","year":"2022","journal-title":"Cells"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80417-3","article-title":"Regulation of btk function by a major autophosphorylation site within the SH3 domain","volume":"4","author":"Park","year":"1996","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.03.012","article-title":"Genetic and demographic features of X-linked agammaglobulinemia in eastern and central Europe: a cohort study","volume":"46","author":"T\u00f3th","year":"2009","journal-title":"Mol Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1086\/301828","article-title":"Mutations in btk in patients with presumed X-linked agammaglobulinemia","volume":"62","author":"Conley","year":"1998","journal-title":"Am J Hum Genet"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9131","article-title":"Bruton tyrosine kinase gene mutations in Argentina","volume":"21","author":"Danielian","year":"2003","journal-title":"Hum Mutat"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9219","article-title":"Italian XLA Collaborative Group of the Italian Pediatric Hematology-Oncology Association (AIEOP). BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia","volume":"23","author":"Fiorini","year":"2004","journal-title":"Hum Mutat"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9262-8","article-title":"Mutation of the BTK gene and clinical feature of X-Linked agammaglobulinemia in mainland China","volume":"29","author":"Wang","year":"2009","journal-title":"J Clin Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5250.822","article-title":"Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases","volume":"271","author":"Rawlings","year":"1996","journal-title":"Science"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.2.461","article-title":"Deletion within the Src homology domain 3 of bruton\u2019s tyrosine kinase resulting in X-linked agammaglobulinemia (XLA)","volume":"180","author":"Zhu","year":"1994","journal-title":"J Exp Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/3.10.1899","article-title":"Unique mutations of Bruton\u2019s tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families","volume":"3","author":"Zhu","year":"1994","journal-title":"Hum Mol Genet"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2004.04076.x","article-title":"Encoded errors: mutations and rearrangements mediated by misalignment at repetitive DNA sequences: Replication slippage","volume":"52","author":"Lovett","year":"2004","journal-title":"Mol Microbiol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2016.1139451","article-title":"Cohort of Iranian patients with congenital agammaglobulinemia: mutation analysis and novel gene defects","volume":"12","author":"Abolhassani","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61075-7","article-title":"De novo mutation in the BTK gene of atypical X-linked agammaglobulinemia in a patient with recurrent pyoderma","volume":"96","author":"Lin","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"197","DOI":"10.21911\/aai.033","article-title":"Mutation in BTK gene causing an atypical presentation of XLA","volume":"20","author":"Esenbo\u011fa","year":"2022","journal-title":"Asthma Allergy Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1252765\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T14:51:29Z","timestamp":1695394289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1252765\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":71,"alternative-id":["10.3389\/fimmu.2023.1252765"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1252765","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2023.1252765.s001","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"article-number":"1252765"}}